Clincosm LogoSign in Get a demo

Bladder Cancer

Showing NaN - NaN of 49
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bladder Cancer Trial in Worldwide (TAR-200, Cetrelimab, BCG Vesiculture)

Not yet recruiting
  • Bladder Cancer
  • Scottsdale, Arizona
  • +241 more
Feb 9, 2023

Bladder Cancer, Patient Engagement, Patient Empowerment Trial in Manhasset, Philadelphia (Cancer Resource Information Support

Recruiting
  • Bladder Cancer
  • +3 more
  • Cancer Resource Information Support (CRIS)
  • Usual Care Enhanced
  • Manhasset, New York
  • +1 more
Feb 2, 2023

Primary and Metastatic Tumors in Renal Cell Carcinoma and

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Immune checkpoint inhibitor targeting PD1
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center - Philadelphia
Jan 27, 2023

Urothelial Carcinoma, Bladder Cancer Trial in United States (drug, radiation, biological)

Recruiting
  • Urothelial Carcinoma
  • Bladder Cancer
  • Durvalumab (Cohort 1-3)
  • +7 more
  • Phoenix, Arizona
  • +10 more
Jan 11, 2023

Bladder Cancer Trial in Worldwide (Atezolizumab)

Active, not recruiting
Has Results
  • Bladder Cancer
  • Birmingham, Alabama
  • +76 more
Dec 6, 2022

Bladder Cancer Trial in Worldwide (Atezolizumab)

Active, not recruiting
Has Results
  • Bladder Cancer
  • Birmingham, Alabama
  • +76 more
Dec 6, 2022

Intravesical Therapy and Surgery as Treatment Options for

Recruiting
  • Bladder Cancer
  • +2 more
    • Birmingham, Alabama
    • +37 more
    Nov 28, 2022

    Bladder Cancer Trial in Philadelphia (social incentive-based gamification)

    Completed
    • Bladder Cancer
    • social incentive-based gamification
    • Philadelphia, Pennsylvania
    • +1 more
    Nov 8, 2022

    Bladder Cancer Trial in United States (N-803 and BCG, N-803)

    Recruiting
    • Bladder Cancer
    • Anchorage, Alaska
    • +31 more
    Oct 26, 2022

    Bladder Cancer Trial in Chapel Hill, Philadelphia (Pembrolizumab, Entinostat)

    Recruiting
    • Bladder Cancer
    • Chapel Hill, North Carolina
    • +1 more
    Oct 10, 2022

    Urothelial Carcinoma, Bladder Cancer Trial in United States (Placebo, Pembrolizumab)

    Completed
    Has Results
    • Urothelial Carcinoma
    • Bladder Cancer
    • Phoenix, Arizona
    • +27 more
    Sep 16, 2022

    Arquer's MCM5 Elisa Test to Aid in Monitoring of Recurrence in

    Recruiting
    • Bladder Cancer
    • ADXBLADDER
    • Denver, Colorado
    • +12 more
    Aug 18, 2022

    Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in Worldwide (UGN-102)

    Recruiting
    • Bladder Cancer
    • +2 more
    • Tucson, Arizona
    • +76 more
    Jul 13, 2022

    Bladder Cancer, Urothelial Carcinoma Trial in United States (OGX-427, Docetaxel)

    Completed
    Has Results
    • Bladder Cancer
    • Urothelial Carcinoma
    • Birmingham, Alabama
    • +34 more
    Jul 7, 2022

    Bladder Cancer Trial in United States (Nivolumab, Gemcitabine, Cisplatin)

    Active, not recruiting
    • Bladder Cancer
    • Duarte, California
    • +6 more
    Jul 7, 2022

    Bladder Cancer Trial in United States (cisplatin, 5-fluorouracil, Mitomycin)

    Active, not recruiting
    Has Results
    • Bladder Cancer
    • Atlanta, Georgia
    • +12 more
    Mar 28, 2022

    Urothelial Carcinoma, Bladder Cancer, Urethral Cancer Trial in United States (Biospecimen Collection)

    Active, not recruiting
    • Urothelial Carcinoma
    • +3 more
    • Biospecimen Collection
    • Los Angeles, California
    • +7 more
    Feb 14, 2022

    Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)

    Completed
    • Prostate Cancer
    • +6 more
    • MGA271
    • Los Angeles, California
    • +11 more
    Feb 4, 2022

    Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

    Terminated
    • Mesothelioma
    • +12 more
    • MGD009
    • Los Angeles, California
    • +19 more
    Feb 4, 2022

    Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)

    Recruiting
    • Urothelial Carcinoma
    • +20 more
    • Gilbert, Arizona
    • +9 more
    Feb 3, 2022

    HER2-positive, Adenocarcinoma, Bile Duct Cancer Trial in United States (CT-0508)

    Recruiting
    • HER2-positive
    • +30 more
    • CT-0508
    • Duarte, California
    • +4 more
    Feb 1, 2022

    Bladder Cancer Trial in United States (Gemcitabine, Cisplatin, Methotrexate)

    Active, not recruiting
    Has Results
    • Bladder Cancer
    • Birmingham, Alabama
    • +565 more
    Dec 3, 2021

    Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in Worldwide (UGN-102, TURBT)

    Active, not recruiting
    • Bladder Cancer
    • +2 more
    • Tucson, Arizona
    • +138 more
    Nov 15, 2021

    Bladder Cancer, Gastric Cancer Trial in Philadelphia (OTL38, ICG)

    Completed
    • Bladder Cancer
    • Gastric Cancer
    • Philadelphia, Pennsylvania
      Hospital of the University of Pennsylvania
    Jun 11, 2021

    Bladder Cancer Trial in United States (Apaziquone, Placebo, TURBT)

    Completed
    Has Results
    • Bladder Cancer
    • Anchorage, Alaska
    • +73 more
    Mar 9, 2021